Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN CARBOGEN AMCIS Gains 6%; BSE HEALTHCARE Index Up 0.7%
Wed, 21 Aug 10:7

DISHMAN CARBOGEN AMCIS Gains 6%; BSE HEALTHCARE Index Up 0.7%Image source: phive2015/www.istockphoto.com

DISHMAN CARBOGEN AMCIS share price has zoomed 6% and is presently trading at Rs 179.3.

Meanwhile, the BSE HEALTHCARE index is at 41,920.4 (up 0.7%).

Among the top gainers in the BSE HEALTHCARE index today are Divis Laboratories (up 3.2%) and ALEMBIC PHARMA (up 3.1%).

Aurobindo Pharma (down 1.2%) and MAX HEALTHCARE INSTITUTE (down 0.5%) are among the top losers today.

Over the last one year, DISHMAN CARBOGEN AMCIS has moved up from Rs 153.6 to Rs 179.3, registering a gain of Rs 25.7 (up 16.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,021.8 to 41,920.4, registering a gain of 49.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 128.3%), Glenmark Pharma (up 114.1%) and GSK Pharma (up 110.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,708.4 (down 0.1%).

The top losers among the BSE Sensex today are Ultratech Cement (down 1.9%) and ICICI Bank (down 0.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,697.8 . Ultratech Cement and ICICI Bank are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,216.1 to 80,708.4, registering a gain of 15,492.3 points (up 23.8%).

DISHMAN CARBOGEN AMCIS Financial Update...

DISHMAN CARBOGEN AMCIS net profit fell 556.3% YoY to Rs -776 million for the quarter ended June 2024, compared to a profit of Rs 170 million a year ago. Net sales declined 27.6% to Rs 5,238 million during the period as against Rs 7,234 million in April-June 2023.

For the year ended March 2023, DISHMAN CARBOGEN AMCIS reported 265.5% decrease in net profit to Rs -298 million compared to net profit of Rs 180 million during FY22. Revenue of the company grew 12.7% to Rs 24,129 million during FY23.

The current Price to earnings ratio of DISHMAN CARBOGEN AMCIS, based on rolling 12 month earnings, stands at -11.3.


Equitymaster requests your view! Post a comment on "DISHMAN CARBOGEN AMCIS Gains 6%; BSE HEALTHCARE Index Up 0.7%". Click here!